199 related articles for article (PubMed ID: 25662994)
21. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
22. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
Szczepanski T; van der Velden VH; Waanders E; Kuiper RP; Van Vlierberghe P; Gruhn B; Eckert C; Panzer-Grümayer R; Basso G; Cavé H; Stadt UZ; Campana D; Schrauder A; Sutton R; van Wering E; Meijerink JP; van Dongen JJ
J Clin Oncol; 2011 Apr; 29(12):1643-9. PubMed ID: 21357790
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
[TBL] [Abstract][Full Text] [Related]
24. The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
Zanetti C; Kumar R; Ender J; Godavarthy PS; Hartmann M; Hey J; Breuer K; Weissenberger ES; Minciacchi VR; Karantanou C; Gu Z; Roberts KG; Metzler M; Stock W; Mullighan CG; Bloomfield CD; Filmann N; Bankov K; Hartmann S; Hasserjian RP; Cousins AF; Halsey C; Plass C; Lipka DB; Krause DS
Blood; 2021 Nov; 138(19):1870-1884. PubMed ID: 34424946
[TBL] [Abstract][Full Text] [Related]
25. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
Filip AA; Ciseł B; Koczkodaj D; Wąsik-Szczepanek E; Piersiak T; Dmoszyńska A
Blood Cells Mol Dis; 2013 Apr; 50(4):263-70. PubMed ID: 23313631
[TBL] [Abstract][Full Text] [Related]
26. Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia.
Almeida RDS; Ramos AML; Luna CF; Pedrosa F; Donadi EA; Lucena-Silva N
Cytokine; 2018 Feb; 102():94-101. PubMed ID: 28802664
[TBL] [Abstract][Full Text] [Related]
27. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
29. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
31. Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.
Hohtari H; Brück O; Blom S; Turkki R; Sinisalo M; Kovanen PE; Kallioniemi O; Pellinen T; Porkka K; Mustjoki S
Leukemia; 2019 Jul; 33(7):1570-1582. PubMed ID: 30635636
[TBL] [Abstract][Full Text] [Related]
32. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice.
Jackaman C; Radley-Crabb HG; Soffe Z; Shavlakadze T; Grounds MD; Nelson DJ
Aging Cell; 2013 Jun; 12(3):345-57. PubMed ID: 23442123
[TBL] [Abstract][Full Text] [Related]
33. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
34. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
35. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
[TBL] [Abstract][Full Text] [Related]
36. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states.
Mulder R; Banete A; Basta S
Immunobiology; 2014 Oct; 219(10):737-45. PubMed ID: 24954891
[TBL] [Abstract][Full Text] [Related]
37. The Role of Tumor-Associated Macrophages in Leukemia.
Li Y; You MJ; Yang Y; Hu D; Tian C
Acta Haematol; 2020; 143(2):112-117. PubMed ID: 31288222
[TBL] [Abstract][Full Text] [Related]
38. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
39. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
Miller SC; Christopher FL; Dussault I
Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro.
Seledtsov VI; Avdeev IV; Seledtsova GV; Samarin DM; Prokopenko IV; Kozlov VA
Biomed Pharmacother; 1995; 49(6):293-9. PubMed ID: 7579011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
